Answers are grounded in this paper and cite their sources.
A procedure is proposed for the assessment of bioequivalence of variabilities between two formulations in bioavailability/bioequivalence studies. This procedure is essentially a two one-sided Pitman-Morgan’s tests procedure which is based on the correlation between crossover differences and subject totals. The nonparametric version of the proposed test is also discussed. A dataset of AUC from a 2×2 crossover bioequivalence trial is presented to illustrate the proposed procedures.
No takes yet. Share an insight, caveat, or question.
Liu et al. (1992) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: